Oral Abstract Session II
Thursday, September 5, 2024 04:45 PM - 05:45 PM
F3
Oral Abstracts
Chair:
Included Abstracts:
- Massimiliano Gnecchi, MD, PhD, University of Pavia, Italy
Included Abstracts:
- Willem Delabie, BSc, Belgian Red Cross Flanders, Belgium - Development of a unified European human platelet lysate
- Dominique Farge, MD, PhD, Hopital Saint-Louis, Universite Paris Cite, McGill University, France - Allogeneic Umbilical-cord derived Mesenchymal Stromal Cells MSC(UC) as treatment for Systemic Lupus Erythematosus (SLE): safety and early clinical/biological results from a phase I-II proof-of-concept clinical study
- L. Rhiannon Hilton, PhD, AstraZeneca, Sweden - Kidney targeting of mesenchymal stem cells for the treatment of acute kidney injury
- Lucienne Vonk, PhD, Xintela AB, Sweden - Treatment with integrin α10β1-selected mesenchymal stem cells promotes wound healing and skin regeneration in a pig model
- Katia Lefsihane, PhD, Karolinska Institutet, Sweden - Mechanisms of MSC phagocytosis by monocytes
- Jesús Chaparro García, BSc, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Spain - Evaluation of virally inactivated human platelet lysates as a supplement for culture media in manufacturing cell-based medicinal products
Jesús Chaparro García
Quality Manager
Andalusian Network for design and Translation of Advanced Therapies
Abstract Presenter
Quality Manager
Andalusian Network for design and Translation of Advanced Therapies
Abstract Presenter
Massimiliano Gnecchi
Professor of Cardiology
University of Pavia & IRCCS Policlinico San Matteo
Chair
Professor of Cardiology
University of Pavia & IRCCS Policlinico San Matteo
Chair